Vous avez cherché: csii (Danois - Anglais)

insulininfusion (csii):
insulin infusion (csii):

et insulininfusion (csii):
or insulin infusion (csii):

csii skal indgives i abdominalvæggen.
csii should be administered in the abdominal wall.

kontinuerlig subkutan insulininfusion (csii)
continuous subcutaneous insulin infusion (csii)

administration via kontinuerlig subkutan insulininfusion (csii)
administration via continuous subcutaneous insulin infusion (csii)

novorapid kan anvendes til csii i pumpesystemer til insulininfusion.
novorapid may be used for csii in pump systems suitable for insulin infusion.

to hurtigt at udvikle ketoacidose ved længerevarende afbrydelse af csii.
patients whose blood glucose control is greatly improved e. g. by intensified insulin therapy, may experience a change in their usual warning symptoms of hypoglycaemia and should be advised ro

patienter som får csii skal instrueres grundigt i brugen af pumpesystemet.
patients using csii should be comprehensively instructed on the use of the pump system.

ris patienter, som påbegynder csii, bør have omhyggelig instruktion i anvendelsen af pumpen og
au when used in a pump.

novorapid kan anvendes i infusionspumpesystemer (csii), som beskrevet i pkt.
novorapid may be used in an infusion pump system (csii) as described in section 4.2.

novorapid kan endvidere administreres som kontinuerlig subkutan insulininfusion (csii) i pumpesystemer.
moreover novorapid can be used for continuous subcutaneous insulin infusion (csii) in pump systems.

novorapid kan anvendes til kontinuert subkutan insulininfusion (csii) i pumpesystemer til insulininfusion.
novorapid may be used for continuous subcutaneous insulin infusion (csii) in pump systems suitable for insulin infusion.

(1) de fleste tilfælde var relateret til håndteringsfejl eller pumpesvigt, når apidra blev givet som csii.
(1) most of the cases were related to handling errors or pump system failure when apidra was used with csii.

apidra kan gives som kontinuerlig subkutan insulininfusion (csii) ved hjælp af pumpesystemer egnede til insulininfusion og brug af passende katetre og reservoirer.
apidra may be used for continuous subcutaneous insulin infusion (csii) in pump systems suitable for insulin infusion with the appropriate catheters and reservoirs.

patienter, som anvender csii, bør instrueres grundigt i brugen af pumpesystemet samt anvende beholdere og slanger, som hører til pumpen (se pkt.6. 6) .
patients using csii should be comprehensively instructed in the use of the pump system and use the correct reservoir and tubing for the pump (see section 6.6) .